Report summary
- The reporting period is 2025/01/01 to 2025/12/31, in the 生技醫療業 industry.
- No third-party verification or assurance provider is listed yet. Use this page to check the report’s verification, assurance, and disclosure standards.
- Compare public disclosure approaches across prior-year and peer reports. Your company’s actual disclosures must still be based on its own data and supporting evidence.
Report details
- Company
- 博晟生醫股份有限公司(6733)
- Reporting Year
- 2025
- Disclosure Period
- 2025/01/01 to 2025/12/31
- Industry
- 生技醫療業
- Third-party information
- No third-party verification or assurance provider information is currently listed.
- PDF source
- The original ESG report PDF can be downloaded or opened from this page
2025 ESG Metrics and Industry Comparison
Greenhouse Gas Emissions
| Scope 1 Emissions (Tons CO2e)Data boundary: 已完成母公司Verification obtained: No | 60 |
| Scope 2 Emissions (Tons CO2e)Data boundary: 已完成母公司Verification obtained: No | 285 |
| Scope 3 Emissions (Tons CO2e)Data boundary: Not disclosedVerification obtained: No | Not disclosed |
Energy Management
| Renewable Energy ShareData boundary: Not disclosedVerification obtained: Not disclosed | Not disclosed |
Water Management
| Water Use (Metric Tons)Data boundary: 本資料僅涵蓋本公司位於【總公司及工廠】之主要營運據點/廠區之用水量,包含生產製程與日常營運用水,未包含其他據點及供應商用水數據。Verification obtained: Not disclosed | 2.4 |
Board of Directors
| Board Seats (Including Independent Directors) | 7 |
| Independent Director Seats | 4 |
| Female Director Ratio Ranked 59 among 97 companies in the same industry (percentile 33). | 14.3% |
| Board Meeting Attendance Rate Ranked 75 among 97 companies in the same industry (percentile 22). | 93% |
| Independent Director Ratio Ranked 2 among 97 companies in the same industry (percentile 92). | 57.1% |
Source: Taiwan Stock Exchange / Taipei Exchange, Corporate ESG Disclosure Summary (2025), under the Open Government Data License, version 1.0. Peer rankings are calculated by Sustaihub (永訊智庫) from this data.(License)
How to use this report
- Compare how 博晟生醫股份有限公司 structured 生技醫療業 sustainability report chapters and material topics in 2025.
- Confirm the reporting period, listed third-party verification or assurance provider information, and the downloadable ESG report PDF source.
- Mark public disclosures and original page numbers that can be referenced as research materials for planning chapters and indicators for your own company.
Reports from the Same Industry
生技醫療業2025
Further reading
When you prepare your own disclosure, these pages are a useful next read.
How to use this public report as a reference
Compare sections, indicators, and disclosure approaches, and go back to the original page numbers for context. Peer content does not reflect your own company's facts; actual disclosures should still be based on your company's data and supporting documents.
The report has opened in a new tab
Next, you can: